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Abstract
We report a novel technology for the rapid healing of large
osseous and chondral defects, based upon the genetic
modification of autologous skeletal muscle and fat grafts.
These tissues were selected because they not only possess
mesenchymal progenitor cells and scaffolding properties,
but also can be biopsied, genetically modified and returned
to the patient in a single operative session. First generation
adenovirus vector carrying cDNA encoding human bone
morphogenetic protein-2 (Ad.BMP-2) was used for gene
transfer to biopsies of muscle and fat. To assess bone
healing, the genetically modified (“gene activated”) tissues
were implanted into 5mm-long critical size, mid-diaphyseal,
stabilized defects in the femora of Fischer rats. Unlike
control defects, those receiving gene-activated muscle
underwent rapid healing, with evidence of radiologic
bridging as early as 10 days after implantation and
restoration of full mechanical strength by 8 weeks.
Histologic analysis suggests that the grafts rapidly
differentiated into cartilage, followed by efficient
endochondral ossification. Fluorescence in situ
hybridization detection of Y-chromosomes following the
transfer of male donor muscle into female rats demonstrated
that at least some of the osteoblasts of the healed bone were
derived from donor muscle. Gene activated fat also healed
critical sized defects, but less quickly than muscle and with
more variability. Anti-adenovirus antibodies were not
detected. Pilot studies in a rabbit osteochondral defect
model demonstrated the promise of this technology for
healing cartilage defects. Further development of these
methods should provide ways to heal bone and cartilage
more expeditiously, and at lower cost, than is presently
possible.
Keywords: Adenovirus, bone morphogenetic protein, large
segmental defects, cartilage repair, bone healing, gene
therapy, animal models, facilitated endogenous repair, tissue
engineering, fibrodysplasia ossificans progressiva.
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Introduction
Tissue engineering approaches to the repair of bone and
cartilage often require the ex vivo expansion of autologous
progenitor cells which are seeded onto scaffolds and
incubated in the presence of morphogens to induce
differentiation. The engineered tissues are then surgically
implanted during a subsequent procedure.  Facilitated
endogenous repair is an alternative strategy that seeks to
expedite the process by delivering genes intraoperatively
to minimally manipulated, autologous tissues that contain
progenitor cells and possess the properties of a space-
filling, inductive or conductive scaffold (Evans et al.,
2007). The use of genetically modified bone marrow
coagulates for cartilage repair is one example of this
approach (Ivkovic et al., 2010; Pascher et al., 2004). As
noted in previous publications (Evans et al., 2007), muscle
and fat are also candidates for use in facilitated
endogenous repair. Here we confirm their ability to
promote the rapid healing of bone and osteochondral
defects in animal models.
As demonstrated by the disease fibrodysplasia
ossificans progressiva (FOP), human muscle has an
enormous capacity to form bone in vivo (Kaplan et al.,
2008). The propensity for bone to form in muscle is also
demonstrated by the frequency of heterotopic ossification
in patients undergoing total hip joint replacement (Stoltny
et al., 2007) and following blast injuries (Forsberg et al.,
2009). Patients with FOP contain an activating mutation
in the gene encoding a bone morphogenetic protein (BMP)
type I receptor (Shore et al., 2006), suggesting that human
muscle forms bone very efficiently in response to BMP
signalling. Gene transfer provides one way to deliver a
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sustained BMP signal (Evans et al., 2004), and we have
extensively used an adenovirus vector (Ad.BMP-2) for this
purpose (Baltzer et al., 2000a; Baltzer et al., 2000b; Betz
et al., 2007a; Betz et al., 2006; Betz et al., 2007b; Betz et
al., 2008; Lieberman et al., 2002). Previous studies in
which a recombinant adenovirus vector was injected
directly into femoral segmental defects created in
experimental animals have shown that nearly all the
transgene is expressed in the muscle surrounding the defect
(Baltzer et al., 1999). The possibility that genetically
modified muscle cells make important contributions to
healing of the adjacent lesion is suggested by the
demonstration of osteoprogenitor cells within skeletal
muscle (Bosch et al., 2000; Mastrogiacomo et al., 2005).
Here we have examined directly the hypothesis that skeletal
muscle has the ability to form bone and heal critical sized
osseous defects when transduced with Ad.BMP-2. Fat is
another tissue known to possess osteoprogenitor cells
(Dragoo et al., 2005) and to have the ability to serve as a
space-filling scaffold. It is readily recovered by, for
instance, liposuction and is thus also of interest for
facilitated endogenous repair.
Because progenitor cells within muscle and fat can also
differentiate into chondrocytes (Kuroda et al., 2006;
Mastrogiacomo et al., 2005; Wickham et al., 2003), there
is the potential to use these tissues as the basis for healing
chondral and osteochondral lesions. The literature suggests
that recombinant BMP-2 can be used for cartilage repair
(Sellers et al., 1997; Sellers et al., 2000), despite concerns
about its ability to induce the hypertrophic differentiation
of chondrocytes as a prelude to bone formation (Steinert
et al., 2009). Thus, we have also performed a pilot study
to determine whether grafts of muscle or fat that have been
transduced with Ad.BMP-2 are able to heal osteochondral
defects in the femoral condyles and trochlear grooves of
rabbits’ knees.
Collectively, the data confirm the merits of this
approach to tissue repair and shed light on the importance
of local, in vivo cues for determining mesenchymal cell
differentiation pathways.
Materials and Methods
Vectors and transduction of muscle and fat
First generation adenovirus (ΔE1, ΔE3), serotype 5,
carrying human BMP-2 cDNA (Ad.BMP-2), firefly
luciferase cDNA (Ad.luc) or green fluorescent protein
cDNA (Ad.GFP) under the transcriptional control of the
human cytomegalovirus early promoter were constructed
by cre-lox recombination (Hardy et al., 1997) as previously
described (Gouze et al., 2004; Palmer et al., 2003). Viruses
were propagated in 293 cells (ATCC, Manassas, VA, USA),
purified on caesium-chloride gradients, and dialysed
against 10 mM Tris-HCl (pH 7.8), 150 mM NaCl, 10 mM
MgCl2, and 4% sucrose buffer. Viral titres were estimated
as 1012 to 1013 particles/ml by optical density and 1010 to
1011 plaque forming units (pfu)/ml by standard plaque assay
(Gouze et al., 2004; Palmer et al., 2003).
Skeletal muscle and fat tissue to be subsequently
implanted were harvested aseptically from donor animals,
placed into 50ml Falcon tubes with complete Dulbecco’s
Modified Essential Medium (DMEM), and transferred to
the laboratory for transduction with adenovirus vectors.
Tissues were carefully cut into 1mm thick slices in Petri
dishes and a skin biopsy punch, diameter 4mm, was used
to punch out uniform, standard 4mm x 1mm discs. Tissue
discs were placed into 24-well plates and transduced with
the indicated amounts of adenovirus particles. A 20μl
suspension of adenovirus was directly dropped onto the
surface of tissue disc in the wells. The plates were returned
to the incubator (37°C and 5% CO2) for 60min. Afterwards
1ml complete DMEM supplemented with 10% foetal
bovine serum and 1% antibiotics was added to each well,
and incubation continued for another 60min. After
removing the transduction medium, 1ml fresh complete
DMEM medium was added to each well and incubation
continued for 3 days. Conditioned media were collected
and BMP-2 concentrations were measured using a
commercial ELISA kit (R&D Systems, Minneapolis, MN,
USA).
In vitro experiments
To estimate the efficiency of gene transfer to cells within
muscle and fat, discs of these tissues were recovered from
rats and transduced with Ad.GFP or Ad.BMP-2, as
described above. GFP+ cells were identified by
fluorescence microscopy, and BMP-2 expression was
determined by ELISA measurement of conditioned media.
All in vitro experiments were repeated in triplicate.
To evaluate a possible osteogenic response of muscle
to transduction with Ad.BMP-2, discs of transduced and
control muscle were maintained in 24-well plates with 1ml
DMEM medium supplemented with 10% foetal bovine
serum and antibiotics. At 10 and 21 days, discs were
recovered, RNA isolated and the abundance of bone and
muscle specific transcripts measured by quantitative, real
time PCR. Discs were homogenized together in TRIzol®
(Invitrogen, Carlsbad, CA, USA), mixed with chloroform,
and RNA was precipitated with isopropanol. After
quantification, RNA integrity was checked by agarose gel
electrophoresis. Oligotex® (Qiagen, Valencia, CA, USA),
mRNA purification reagent, was used to purify mRNA
from total RNA according to standard protocols.
RETROscript™ (Ambion, Austin, TX, USA) first strand
synthesis kit was used to reverse transcribe mRNA to
cDNA according to standard protocols. In brief, mRNA
(100 ng) was reverse transcribed with M-MLV reverse
transcriptase in 20 μl. The cDNA was diluted 5X and used
as template for RT-PCR.  Real-time quantitative RT-PCR
was used to evaluate mRNA levels using an ABI PRISM®
7700 sequence detection system (Applied Biosystems,
Foster City, CA, USA). We have previously described the
real-time RT-PCR conditions (Hofstaetter et al., 2004;
Hofstaetter et al., 2005; Hofstaetter et al., 2007). Briefly,
the reactions were run in triplicate, each containing 1 μl
cDNA along with 2.5 pmoles of gene specific primers
(Table 1) in a final volume of 25 μl with the following
thermal profile: 5 min initial denaturing step to activate
the DNA polymerase, then 40 cycles each at 95°C for 35
sec, 60°C for 45 sec, and 72°C for 45 sec. Levels of
GAPDH transcript proved to be stable under the
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experimental trials; therefore it was selected as a reference
gene. The SYBR green detection system was used. Relative
Expression Software Tool (REST©) was used to analyze
mRNA expression levels, Ct values (Pfaffl, 2001; Pfaffl et
al., 2002), with data expressed as fold induction relative
to controls.
Other discs were used to assay alkaline phosphatase
(ALP) enzyme activity using a colorimetric assay based
upon the conversion of p-nitrophenol phosphate to p-
nitrophenol using a commercially available kit (Sigma
Chemical Co., St Louis, MO, USA). To determine whether
the genetically modified discs deposited mineral, certain
samples were processed for histology, as described below,
and stained with alizarin red.
Rat femoral segmental defect model
Because rats are too small for convenient autografting,
donor rats were euthanized and used as a source of muscle
and fat, harvested from the thighs. Initially, Sprague-
Dawley rats were used for this purpose, but gave variable
results. Once informed that this strain of rat is not
completely syngeneic, Fischer rats were used because
individuals within this strain are completely inbred and
can thus accept transplants from other Fischer rats without
mounting an allograft response (T.J. Gill, personal
communication, December 2005). For most experiments,
groups of 10 rats per group were used.
Segmental defects, 5mm in length were created in the
right femora of adult male rats weighing 400-425g, using
Table 1. Primers used to amplify rat bone and muscle markers 
 
 
Gene primer sequences 
               5’ to 3’ 
Td Amplicon Accession number 
 
Bone markers 
 
Rat Osteocalcin  
F gcc cag cga ctc tga gtc tg 
R cca atg tgg tcc gct agc tc 
 
67.2 
67.2 
285 bp M23637 
Rat Bone Sialoprotein  
F gta ccg gcc acg cta ctt tc 
R cca gcg tca gct gtg gtc tc 
 
66.5 
68.0 
264 bp 
 
DQ213013 
Rat Alkaline phosphatase  
F ccc tgc aac cat cat gga ac 
R gaa ggg ttg gcg agt ctc tg 
 
67.4 
66.2 
260 bp J03572 
Rat Osteopontin  
F gcc agc ctg gaa cat cag ag 
R aag ctc agg gcc caa aac ac 
 
67.1 
68.2 
289 bp M14656 
Rat Collagen I alpha 1  
F ggg gtg gga agg aat ttc tg 
R tag gga gca gca gca aga gg 
 
67.3 
67.2 
275 bp XM_213440 
Rat Cbfa1  
F agt ggc cag gtt caa cga tc 
R tgc gcc cta aat cac tga gg 
 
66.3 
67.8 
221 bp AB025797 
Muscle markers 
Rat Myosin 1 
F aag cag cta gta agg gtg act ttc  
R ctc act taa ggg aca gcg act tc   
 
 
65.2 
66.7 
250 bp X68199 
 
Rat Actin alpha 
F tcc cag cac cat gaa gat taa g   
R agg ttg caa gtc ctg gtc tg   
 
 
66.1 
64.0 
329 bp NM_019183 
 
Housekeeping gene 
 
Rat Gapdh   
F aag ggc atc ctg ggc tac ac 
R gag gcc atg tag gcc atg ag 
 
68.0 
66.9 
188 bp AF106860 
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the methods described in detail by Betz et al. (2006).
Briefly, animals were anaesthetised with isofluorane and
the right femur surgically exposed. An external fixator
(described in Betz et al., 2006) was attached to the femur
and a 5-mm osteotomy was then performed with use of a
sterile, round dental burr attached to a dental handpiece.
Test materials were then placed into the defect (Fig. 1).
After copious irrigation, the surgical site was closed in
layers and antibiotics and analgesics administered.
As a positive control, defects received 11μg rhBMP-2
(produced in CHO cells) delivered on a collagen sponge.
Negative controls received unmodified fat or muscle, or
fat and muscle that had been transduced with Ad.luc or
Ad.GFP. Other negative controls received nothing and
remained as empty defects. In the first series of
experiments, defects were monitored by weekly
radiography and animals were euthanized by CO2
asphyxiation eight weeks after surgery. The quality of the
healed bone was evaluated post-mortem by dual-energy
X-ray absorptiometry (DXA), micro-computed
tomography (μCT), mechanical testing in torsion and
Figure 1. Insertion of genetically modified muscle into
femoral defect. Intraoperative image showing the 5mm
femoral defect with external fixator in place. Inset
shows a stack of muscle discs ready to be inserted into
the defect.
Figure 2. In vitro genetic transduction and osteogenic responses of rat muscle discs.
(a) 4mm diameter disc of rat muscle after transduction with Ad.GFP, viewed under fluorescence microscopy. Inset
shows freshly isolated disc near the end of the tissue punch.
(b) Production of BMP-2 following transduction with Ad.BMP-2. Discs were transduced with 106, 107, 108 or 109
pfu Ad.BMP-2. Control discs received 109 pfu Ad.GFP or remained untransduced. Media were changed every 3
days and BMP-2 concentrations determined by ELISA. Symbols: *- significant difference from control, # - significant
difference from discs transduced with 109 pfu Ad.BMP-2, $ - significant difference from discs transduced with 108
pfu Ad.BMP-2.
(c) Alkaline phosphatase activity of naïve muscle discs, and discs transduced with Ad.BMP-2 or Ad.GFP. *- significant
difference from untreated disc, # - significant difference from disc transduced with Ad.GFP
(d) Alizarin red staining of untreated muscle discs and discs transduced with Ad.BMP-2 at 21 days.
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histology. In certain experiments, control animals receiving
unmodified muscle were euthanized after 12 weeks.
Dual-energy X-ray absorptiometry (DXA)
We assessed the bone mineral content (g) of the defect
region by dual-energy X-ray absorptiometry (PIXImus 2;
GE-Lunar, Madison, WI, USA). Specimens were placed
on a Lucite block during scanning to simulate soft tissue.
The scans were acquired using small animal high-
resolution mode. All excised femora were evaluated after
8 weeks of treatment in the area corresponding to the region
of the critical-sized segmental bone defect.
Microcomputed tomography (μCT)
All femora were scanned using a desktop
microtomographic imaging system (μCT40; Scanco
Medical AG, Bassersdorf, Switzerland) equipped with a
10mm focal spot microfocus X-ray tube. Femora were
scanned using a 16mm isotropic voxel size at 55keV
energy, 200ms integration time with approximately 720
μCT slices per specimen. Evaluation was done only in the
4mm central defect region to ensure that no pre-existing
cortical bone was included in the analyses. To evaluate
the region of interest, we assessed the following variables:
total cross-sectional area of the defect (mm2) and bone
area (mm2). Images were thresholded using an adaptive–
iterative algorithm and morphometric variables were
computed from the binarized images using direct, three-
dimensional techniques that do not rely on any prior
assumptions about the underlying structure.
Ex vivo torsion testing
After all noninvasive imaging was complete specimens
were tested to failure in torsion to determine healed defect
mechanical properties in shear. Both ends of each specimen
were embedded in PMMA to provide a reproducible
gripping interface with the testing fixture. All femora were
tested to failure under regular deformation control and at
the constant deformation rate of 5rad/min. Angular
deformation and applied load data were acquired at 10Hz.
The torque and rotation data were used to calculate the
torsional stiffness and strength of the healed defect.
Histology
After evaluation by μCT and DXA the specimens were
decalcified for 6 to 8 hours in RDO Rapid decalcifier (Apex
Engineering, Aurora, IL, USA) testing with a needle as
the decalcification proceeded. Fixed and decalcified tissues
were dehydrated in graded ethanol up to 100%, transferred
to xylene, and embedded in paraffin. Five-micron paraffin
sections were placed on poly L-lysine-coated slides, dried
overnight, and evaluated immediately or stored at 4oC.
Sections were stained with safranin O-fast green to detect
the presence of cartilage or alizarin red to detect
mineralized deposits.
Fluorescence in situ hybridization (FISH)
FISH was performed with the rat Y/12 chromosome paint
(Cambio, Cambridge, UK), according to the
manufacturer’s instructions. Briefly, tissue sections were
de-waxed in xylene, transferred to industrial methylated
spirits and then washed in 0.4% sodium thiocyanate at 80oC
Figure 3. Expression of bone and muscle related genes by muscle discs after transduction with Ad.BMP-2. RNA
was extracted and quantitative, real-time PCR performed 10 and 21 days after gene transfer using the techniques
described in Materials and Methods. Expression is expressed as fold induction or reduction compared to controls.
BSP = bone sialoprotein; ALP = alkaline phosphatase.
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for 10 minutes. Sections were then permeabilised with
0.4% pepsin/0.1M HCl. Following permeabilisation,
sections were post fixed in 4% paraformaldehyde/
phosphate buffered saline (PBS), dehydrated and air-dried.
Chromosome paint (15μl) was applied to each section and
sections were denatured at 60oC for 10 minutes and then
left to hybridise overnight at 37oC. Following hybridization
a series of stringency washes were performed at 37oC (50/
50 deionised formamide/2 X sodium chloride–sodium
citrate (SSC) for 15 minutes; 2X SSC for 15 min; 4X SSC
containing 0.1ml 10% Tween 20) and then slides were
washed in PBS. Sections were then mounted using
ProLong Gold anti-fade reagent with DAPI (Invitrogen)
and allowed to cure for 24hrs at room temperature in the
dark. All slides were analyzed with a Zeiss
(www.zeiss.com) fluorescence microscope. The Y-FISH
probe was validated using rat testes.
Immunological methods
Peripheral blood was recovered from 3 rats that had
received unmodified muscle, 3 rats that had received gene-
activated muscle or fat, and 3 rats that had been injected
intra-dermally with 5.5x1010 viral particles Ad.BMP-2
(positive control).
Levels of anti-adenovirus antibodies in sera were
assessed by ELISA.  Standard 96-well Nunc ELISA plates
were coated overnight with 5x109 adenoviral particles/ml
suspended in phosphate buffered saline (PBS) (50μl/well).
Plates were blocked by a 1-hour incubation with 1%
Bovine Serum Albumin/PBS (100μl/well). Serum samples
were subjected to serial dilution in PBS/0.5% FCS/0.5%
Tween 20 and added to duplicate wells overnight (50μl/
well). Plates were then incubated with anti-rat IgG ALP
conjugate diluted (1/2500) in PBS/0.5% FCS/ 0.05%
Tween 20 for 2 hours, washed, and subsequently incubated
with 1mg/ml p-nitro-phenyl phosphate substrate in order
to detect plate-bound antibodies. The optical densities of
the plates were read on a Precision Microplate Reader
(Molecular Devices, Sunnyvale, CA, USA) at 405nm.
Rabbit osteochondral defect model
New Zealand white rabbits weighing 2.5kg were used for
this pilot study of 3 animals per group. Because these
animals were large enough to provide autografts,
subcutaneous fat and dorsal muscle biopsies were first
removed from the rabbits and transduced with 109 pfu
Ad.BMP-2, as described above. One week later, rabbits
were anaesthetized and their right femoro-tibial joints were
Figure 4. Serial radiographs of defects in rat femora following the implantation of gene-activated muscle and fat
grafts. Control defects received tissue grafts transduced with control virus carrying marker genes. Radiologic bridging
can be seen in as little as 10 days when using Ad.BMP-2 modified muscle grafts. Healing is slower using Ad.BMP-
2 modified fat, with radiolucency at 10 days, and bridging seen only by 2 weeks. Images from 2 weeks onward (fat)
and 4 weeks onwards (muscle) show the best and worst healers, based on radiologic appearance, in each group of
10 rats.
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surgically exposed. Osteochondral defects of 3mm
diameter and 6mm depth were drilled into the trochlear
groove or the medial femoral condyle. Defects were left
as empty controls, implanted with unmodified tissue grafts
or implanted with grafts that had been transduced with
Ad.BMP-2. Rabbits were euthanized after 6 weeks and
the distal femora removed for decalcification and paraffin
histology, using safranin O-fast green, as described above.
Statistical Analysis
Comparisons of continuous variables between two
treatment groups were performed using a two-tailed t-test,
and between three groups by analysis of variance (One
Way-ANOVA). If the difference between the control and
the treatment groups was significant, a post-hoc test
(Tukey) was performed. Each in vitro experiment was
repeated three times. Differences were considered
statistically significant at p<0.05. Data are presented as
mean ± standard error (SE), unless otherwise noted.
Results
In vitro genetic modification and osteogenic
differentiation of rat skeletal muscle
Discs of rat skeletal muscle were readily transduced with
adenovirus vectors. As shown in Fig. 2a, large numbers of
mononuclear cells within the biopsies became GFP+ after
transduction with Ad.GFP. Discs transduced with
Ad.BMP-2 secreted BMP-2 into their culture media in a
dose-dependent manner for at least 9 days, reaching a
steady state concentration of approximately 5ng/ml in a
72h period (Fig. 2b) when 109 pfu Ad.BMP-2 were used.
Because the total culture volume is 1ml, this equates to
5ng BMP-2/disc/72h. Induction of osteogenesis was
indicated by expression of alkaline phosphatase activity
in muscle discs transduced with Ad.BMP-2, but not
Ad.GFP (Fig. 2c) and the deposition of a mineralized
matrix (Fig. 2d).
Quantitative, real-time PCR measurements revealed
that muscle discs transduced 10 or 20 days earlier with
Ad.BMP-2 showed a dramatic induction of transcripts
Figure 5. Micro-computed tomography images 8 weeks after surgery. Images are shown three dimensionally (top
row), in longitudinal sections (middle 2 rows) and cross section (bottom row).
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associated with osteogenesis, including the transcription
factor CBFA1 (Runx2), osteopontin, Col1A1, bone
sialoprotein (BSP), alkaline phosphatase (ALP) and
osteocalcin. Transcripts encoding muscle specific actin and
myosin, in contrast, were slightly reduced (Fig. 3).
Although the Ad.BMP-2 transduced muscle expressed
genes associated with osteogenesis and deposited a
mineralized matrix, it retained the morphology of muscle
(Fig. 2d).
Repair of femoral segmental defects using genetically
modified muscle
The Sprague-Dawley rats used in initial experiments gave
very variable results. In any group of animals,
Figure 6. Quantitative data from micro-computed tomography and dual energy X-ray absorptiometry. Values given
are means + standard deviation (SD) (n=10).
Symbols: *- significant difference from contralateral femur; # - significant difference from AdBMP-2 activated
muscle graft; $ - significant difference from AdBMP-2 activated fat graft.
Figure 7. Mechanical properties of defects 8 weeks after implantation of Ad.BMP-2 activated muscle and fat. There
are no statistically significant differences between the strength and stiffness values obtained with the contralateral
femur, Ad.BMP-2 activated fat and Ad.BMP-2 activated muscle. Empty defects and control defects receiving
unmodified or Ad.luc modified muscle and fat were too weak to be tested.
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Figure 8. Histological examination of rat femora after implantation of gene-activated muscle and fat grafts. All
sections were stained with safranin O-fast green after euthanasia at the indicated time points after surgery. Low
power (D,E,F,G,H,J) and high power (A,B,C,I,) images are shown (bar = 2mm low power, bar = 200μm high
power). Arrows in panel C point to areas of residual proteoglycan.
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approximately one-third of the defects would undergo
dramatic healing, one-third would heal slowly, and one-
third would fail to heal (data not shown). It was pointed
out that Sprague-Dawley rats are not syngeneic, unlike
Fischer rats (T. J. Gill personal communication, December
2005). For this reason, all further experiments were
conducted with Fischer rats.
Serial radiographs of the defects in Fischer rats
confirmed that empty defects and control defects receiving
unmodified muscle or muscle transduced with Ad.luc did
not heal. Implantation of muscle discs transduced with
Ad.BMP-2, in contrast, underwent rapid healing with
evidence of bridging in as little as 10 days (Fig. 4). Healing
was also notable because of the high degree of uniformity
between the different rats in the group. Figure 4 shows the
best and worst healers, based on radiologic appearance, at
later time points; these are remarkably similar. Moreover,
very little callus was evident.
μCT images taken eight weeks after surgery confirm
healing in all Fischer rats receiving Ad.BMP-2 transduced
muscle, but not controls (Fig. 5). In longitudinal and cross
sectional imaging, μCT revealed the formation of cortical
bone with presence of trabecular bone within the healed
Figure 10. Humoral responses to adenovirus following
implantation of transduced muscle and fat. ELISA
measurement (units of optical density at 405nm) of
antibody binding to adenovirus particles using serum
obtained from rats receiving grafts of unmodified
muscle, Ad.BMP-2 activated fat or Ad.BMP-2
activated muscle. As a positive control animals received
an intradermal injection of Ad.BMP-2. Value are means
+ SD. * - significantly different from positive control.
Figure 9. FISH identification of osteoblasts with Y-chromosomes in female rats. Femoral defects in female animals
received Ad.BMP-2 transduced muscle from male donors. After 8 weeks, recipient rats were euthanized and sections
stained with DAPI (right panels) or subjected to FISH (left panels) using probes specific for sequences unique to
the Y-chromosomes of rats. The bottom left hand panel shows lining osteoblasts (arrowed) that possess a Y-
chromosome. Rat testis (top two panels) is shown as a positive control. A Y-chromosome positive testis cell is
arrowed in the top, left panel. Bar = 100μm
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diaphyseal region of the femur. However, the smooth
contours of the contralateral femur had not been restored
by 8 weeks. Nevertheless, the quantitative μCT and DXA
data (Fig. 6) demonstrate that the total volume, bone
volume, polar moment of inertia and bone mineral content
exceeded that of the contralateral femur, and full
mechanical strength and stiffness had been restored (Fig.
7).
Histology was used to gain more information about
the biological basis of the ability of the gene-activated
muscle to heal the femoral defects in the Fischer rats (Fig.
8). Two weeks after the implantation of muscle discs
modified with Ad.luc, sections showed only muscle
surrounded by a highly cellular fibrous tissue (Fig. 8A).
Many of the infiltrating cells appeared to be leucocytes,
suggesting an inflammatory response. In sharp contrast,
at the same 2-week time point there was no evidence of
muscle in defects receiving muscle discs transduced with
Ad.BMP-2. In its place, there was abundant cartilage as if
the muscle had undergone chondrogenic differentiation en
masse (Fig. 8B). Fibrous soft tissue was absent. The edges
of the cartilage were surrounded by bone (hence the
appearance of bridging on plane X-ray) and gave the
appearance of hypertrophy and ossification. By 4 weeks
(Figs. 8C, D) the cartilage had been almost entirely
replaced by bone, the cortices were forming and marrow
was present. Some residual soft tissue was apparent at this
time in certain sections. By 8 weeks, healing was well
advanced with abundant cortical and intramedullary bone
(Fig. 8F), in agreement with the μCT images shown in
Fig. 5. Control defects receiving muscle transduced with
Ad.luc showed only amorphous soft issue within the defect
at 8 weeks (Fig. 8E). Of interest, certain 12-week control
defects that had received unmodified muscle showed
evidence of spontaneous chondrogenesis (Figs. 8I,J). This
was not associated with ossification.
To determine whether osteoblasts within the healed
bone were of donor or host origin, we transferred gene-
activated muscle from male donors into female recipients
and identified cells at the recipient site containing a Y-
chromosome by FISH. As shown in Fig. 9, this method
identified cells with Y-chromosomes on the surface of the
healed bone, confirming that at least some of the osteoblasts
in the repair tissue were of donor origin.
Repair of femoral segmental defect using genetically
modified fat
Key experiments were repeated using gene-activated fat
instead of muscle. Cells within discs of fat were readily
transduced with Ad.GFP (data not shown). Gene-activated
Figure 11. Macroscopic images of control osteochondral defects and defects treated with gene-activated muscle
and fat. Rabbits were euthanized 6 weeks after surgery. Arrows indicate site of original defect and implantation of
tissue. Bar = 5mm
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fat was able to heal the femoral defects (Fig. 4) but, based
upon radiologic criteria, not as rapidly as gene-activated
muscle. Bridging was not observed until 2 weeks. By 8
weeks, the femora healed with gene-activated fat had
achieved full mechanical strength and stiffness (Fig. 7).
μCT analysis at 8 weeks confirmed the formation of bone
throughout the defect with partial restoration of cortices
and the presence of trabecular bone (Fig. 5). Histology at
8 weeks showed a similar picture to that seen with gene-
activated muscle, with little sign of cartilage or residual
fat. Control defects contained only soft tissue (Fig. 8). The
data shown in Figs. 4, 5, 6, 7 and 8 were from a single
experiment using fat from a single donor. When the
experiment was repeated using additional donors, healing
was of variable quality (data not shown), which, as
discussed later, may reflect heterogeneity of fat from
different sources.
Figure 12.  Histological examination of osteochondral defects receiving gene-activated muscle and fat grafts.
Sections were stained with safranin O-fast green. Bar = 1mm
108 www.ecmjournal.org
C.H. Evans et al.                                                                                    Gene tissue grafts for bone and cartilage repair
Immune response to adenovirus
As shown in Fig. 10, the intra-dermal injection of Ad.BMP-
2 into rats elicited a strong humoral response with the
production of antibodies recognizing adenoviral particles.
No such responses, however, occurred following the ex
vivo implantation of gene-activated fat and muscle and
anti-adenovirus levels were no greater than those found in
animals receiving unmodified tissue (Fig. 10).
Repair of osteochondral defects in rabbits using
genetically modified muscle and fat
Macroscopic examination suggested that defects treated
with either gene-activated muscle or gene-activated fat had
healed (Fig. 11). Histology confirmed that untreated defects
did not heal, but filled in with amorphous soft tissue.
Although some sections contained areas that stained
positively with safranin O, there was no evidence of
widespread chondrogenesis (Fig. 12). Untreated muscle
grafts did not improve healing of the condylar defects but,
interestingly, showed improved healing of the trochlear
groove defects with significant formation of cartilage
staining strongly with safranin-O (Fig. 12). Muscle grafts
transduced with Ad.BMP-2, in contrast, considerably
improved healing of both the condylar and trochlear groove
defects, with the formation of a proteoglycan rich articular
surface with sub-chondral bone beneath, and good union
with the adjacent, intact cartilage (Fig. 12). Overall, healing
was more consistent in the trochlear groove than on the
condyles. Fat grafts transduced with Ad.BMP-2 also
improved the healing of defects in the condyles and,
especially, the trochlear groove where a smooth,
proteoglycan rich articular surface was regenerated with
good fusion with the adjacent, uninjured cartilage (Fig.
12). Like muscle, unmodified fat demonstrated some
ability to regenerate cartilage within the defect.
Discussion
From the data presented in this paper, we conclude that
gene-activated muscle and fat provide promising, novel
opportunities for the rapid regeneration of bone, cartilage
and perhaps other connective tissues. In the present studies
tissue biopsies were transduced with Ad.BMP-2 and
implanted in animals some days later, after we had
confirmed adequate transgene expression. However,
because genetic modification with adenovirus can be
accomplished in 2 hours or less, the entire process should
be achievable within a single operative procedure thus
reducing cost and complexity, as well as sparing the patient
a second invasive procedure.
The remarkable potency of this technology is likely to
stem from its ability to provide simultaneously the three
major requirements of tissue repair: a space filling scaffold;
a source of progenitor cells; an inductive stimulus. Healing
of large segmental defects in response to rhBMP-2 is
known to occur via an endochondral process (Yasko et
al., 1992). Because the periosteum is intentionally removed
at the time of surgery, there is no immediate source of
progenitor cells in this critical sized femoral defect model.
Thus healing is delayed until alternative progenitors arrive
from other sources, possibly the bone marrow, surrounding
muscle or the periosteum of adjacent, intact bone (Yasko
et al., 1992). The direct implantation of tissues that contain
progenitor cells thus eliminates what may be the rate
limiting process for repair under these circumstances –
recruitment of progenitors. The absence of periosteum is
also likely to account for the lack of an exuberant callus
surrounding the defects as they heal.
Histological examination of defects receiving gene-
activated muscle suggests a rapid and efficient conversion
of muscle into cartilage. Although histology only provides
a snap shot, the images indicate efficient ossification
occurring at the edges of the cartilage, and by week 4,
cartilage is no longer present. In this respect the
hypertrophic cells at the edge of the cartilage resemble the
borderline chondrocytes described by Bianco et al. (1998),
suggesting that these cells can differentiate into osteoblasts
rather than undergoing apoptosis and being replaced by
host osteoblasts. Gerstenfeld et al. (2002) have shown that
chondrocytes secrete factors with the ability to induce the
osteogenic differentiation of mesenchymal progenitor cells,
raising the alternative possibility that the graft induces the
formation of osteoblasts from host osteoprogenitor cells.
To determine whether the newly formed bone was of donor
or host origin, we transplanted muscle from male donors
into female rats and identified cells bearing Y-
chromosomes by FISH. The data confirm that at least some
of the osteoblasts lining new bone formed within the defect
are of donor origin. This finding also reinforces the
conclusion that the gene-activated implant is not merely
serving as an efficient, local source of BMP-2, but also
providing progenitor cells. This is consistent with the
observation that the process is only reliably effective when
grafting tissue between entirely syngeneic, Fischer rats.
The unreliable response of the Sprague-Dawley rats
presumably reflects a variable degree of inter-animal MHC
mis-match and rejection of the allograft.
It is noteworthy that, although muscle discs transduced
with Ad.BMP-2 expressed markers of osteogenesis and
deposited a mineralized matrix under in vitro conditions,
they appeared first to form cartilage under in vivo
conditions. Although the direct differentiation of
mesenchymal progenitor cells into osteoblasts might seem
a more expeditious route to bone formation in segmental
defects, the endochondral route provides certain
advantages. Unlike bone formation, chondrogenesis does
not require a blood supply. Indeed, during the endochondral
process, cartilage secretes soluble angiogenic factors that
promote the ingrowth of blood vessels (Petersen et al.,
2002). Thus it is not necessary to supply angiogenic factors
exogenously, either as proteins or genes. This is a major
advantage, especially when considering scaling up from
the rat to large animals, such as sheep and, eventually,
humans. In the larger animals, critical sized defects in long
bones are likely to be hypoxic, a condition that favours
chondrogenesis, but impairs direct osteogenesis.
By forming osteoblasts under in vitro conditions but
chondrocytes in vivo, the muscle discs demonstrate the
importance of the local environment in determining cell
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fate; local cues may be mechanical, as well as chemical
and biological. Their importance is most dramatically
shown in the experiments where gene-activated muscle
and fat grafts were used to repair osteochondral defects in
rabbits. After implantation, the top portion of the implant
within the cartilage defect formed cartilage, and the lower
portion within the sub-chondral bone formed bone, even
though the implants were, to the best of our knowledge,
homogeneous. The strong influence of the local in vivo
environment on differentiation may help to explain why
rhBMP-2 is able to heal cartilage lesions in experimental
animals without producing hypertrophy and mineralization
(Sellers et al., 1997; 2000), whereas in vitro data suggest
otherwise (Steinert et al., 2009). Local influences may also
explain the spontaneous formation of cartilage by
unmodified muscle grafts placed within osteochondral
defects and certain femoral defects at late time points.
With both gene activated muscle and fat, healing of
defects within the rabbits’ trochlear groove was more
complete than healing of condylar defects. This probably
reflects the harsher mechanical environment of the femoral
condyle. Because animals were euthanized after 6 weeks,
it is not possible to comment on the durability of the repair.
However, these preliminary results are encouraging
because there is good integration of the grafts with the
surrounding intact cartilage, and reconstitution of the sub-
chondral bone. Moreover, the repair tissue has abundant
proteoglycan. The experiments performed in this
investigation studied an osteochondral defect, but the
technique should also work for partial thickness cartilage
defects because it does not rely upon the migration of
chondroprogenitor cells from ectopic sites. The technology
may also be extended to additional connective tissues, and
we have preliminary supporting evidence in the context
of tendon healing (Majewski et al., 2008).
Although fat showed promise as a tissue for use in
endogenous facilitated repair, its effects were less reliable
than those of muscle when healing bone. The reason for
this was not thoroughly investigated, but it is our
impression that the donor fat was very variable in its
consistency, vascularity and cellularity from animal-to-
animal, and also between different sites on the same animal.
In agreement with this, Tomiyama et al. (2008) have
reported cellular differences between the abdominal and
sub-cutaneous fat pads in rats. Too few rabbits were studied
to permit conclusions to be drawn concerning the
reproducibility of the ability of fat to heal osteochondral
lesions.
The use of an expedited, ex vivo gene transfer protocol
for gene delivery reduces the safety concerns that always
burden the clinical use of gene therapy. In particular,
because the tissue grafts are transduced with Ad.BMP-2
outside the body, no adenovirus particles are introduced
into the patient. Our data suggest that this eliminates the
humoral response to the virus, thereby lowering the risk
of severe immune reactions of the type that have already
caused the death of one subject in a gene therapy trial using
adenovirus (Raper et al., 2003). However, cells transduced
with first generation adenovirus express viral proteins on
their cell surface, which could trigger cell-mediated
immunity (Ritter et al., 2002). The significance of this in
the present context remains to be determined. In this regard,
alternative vectors and non-viral delivery systems could
be of interest.
In conclusion, these data demonstrate the remarkable
potential of genetically modified, autologous muscle and
fat grafts to heal large defects in bone and cartilage. Their
potency is likely to reflect the presence of endogenous
progenitor cells, the secretion morphogenetic signals by
the genetically modified cells and the scaffolding properties
of the tissues themselves. Because all manipulations can
be carried out within the time frame of a single surgery,
the complexity of the procedure is reduced, which should
lower costs considerably. Further investigation of the
biology that underlies these responses and their evaluation
in large animal models should lead to the development of
effective human protocols.
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Discussion with Reviewers
Reviewer I: The use of adenoviral vectors remains an issue
for some people, what would you see as the most promising
alternative gene transfer strategy?
Authors: If adenovirus vectors are not permissible, adeno-
associated virus (AAV) is the most promising alternative.
It is safe and increasingly used in human gene therapy.
Moreover, AAV generates a weaker immune response than
adenovirus vectors. The genome of wild-type AAV consists
of single stranded DNA, so transgene expression from a
recombinant AAV vector used to be limited by the need
for second strand DNA synthesis. Recent advances in AAV
technology permit the production of AAV vectors with
double stranded genomes, which greatly improves
expression. Although the AAV genome is small (~2kb
packaging for a double stranded vector), cDNAs encoding
growth factors such as BMP-2 are small enough to fit
comfortably. It is still a challenge to manufacture large
amounts of clinical grade vector, but technological
improvements continue to be made on this front, too.
However, AAV is more expensive to manufacture than
adenovirus.
Of the other vectors, pseudotyped lentivirus is very
powerful but its approval for human clinical use in non-
lethal conditions such as bone healing will be very difficult,
because it is an integrating retrovirus with the potential to
cause insertional mutagenesis and, hence, cancer. Non-
integrating lentiviruses are being developed. The
commonly used oncoretroviral vectors are not useful
because they require host cell division for efficient
transduction.
Suitable non-viral vectors would be very welcome,
because they should be less expensive and raise less safety
concerns than viral vectors. However, in our experience,
they are too inefficient for present purposes. This is an
area of considerable research, so efficient non-viral vectors
may become available in the not too distant future. There
is considerable interest in using electroporation as one such
modality.
Reviewer I: Regarding the different pathways taken by
Ad.BMP2 transduced cells in vivo and in vitro, have the
authors tried the same procedure in vitro under hypoxic
conditions to determine the role of oxygen?
Authors: No, but this would be an interesting project, with
the hypothesis that hypoxic conditions favour
chondrogenesis. The role of mechanical factors should also
be a fruitful area of investigation.
Reviewer II: Concerning the bone defect filled with un-
treated muscle, the authors showed the presence of cartilage
after 12 weeks, while in the AdBMP-2 condition, this was
observed after 2 weeks. Is it possible that the non-treated-
muscle may also end up with bone formation, but at later
time?
Authors: This is possible, but, unlike the 2-week Ad.BMP-
2 images, the histology shows no evidence of an
endochondral process. It is more likely that the non-treated
muscle will end up as an atropic non-union or
pseudarthrosis.
